Why Has Nuvama Retained a Buy on ICICI Prudential Life After Q2FY26 Results?
ICICI Prudential Life Insurance’s Q2FY26 results reflected resilience in margins despite a decline in retail business volumes. Nuvama Institutional Equities maintained its “Buy” rating with a target price of ₹770, citing the insurer’s healthy product mix, steady margin trajectory, and consistent management commentary on long-term growth.
The insurer reported a 7% YoY drop in retail APE, which dragged total APE down by 3.3% YoY. However, group APE saw a strong 20.7% YoY surge, aided by an 87.5% jump in the group savings segment. Nuvama highlighted that this portfolio shift demonstrates increasing institutional traction and diversification within the product base.
For insights into insurance regulations and long-term portfolio strategies, visit Option Tip and SEBI Advisory for expert guidance.
The protection share improved by 50 basis points YoY, sustaining a robust Value of New Business (VNB) margin of 24.4%. Management stated that despite the GST exemption-driven top-line push, VNB growth would remain consistent. The company expects FY26–28 VNB margins to gradually stabilize even as product rationalization continues.
Nuvama revised APE and VNB margin estimates marginally downward — by 0.3%/4.5%/7.5% for FY26E/27E/28E respectively — due to regulatory and ITC-related impacts. However, the brokerage rolled valuations forward to Sep-27E, implying a fair-value P/EV multiple of 1.4x FY27E and 1.2x FY28E. The Buy call remains intact, supported by product diversification and disciplined cost controls.
ICICI Prudential continues to leverage its brand strength, bancassurance partnerships, and protection-led focus to maintain steady growth despite short-term volume headwinds. Analysts expect consistent traction in group savings, annuity, and protection businesses to drive APE recovery in the coming quarters.
For policy-driven insights on financial institutions and evolving SEBI-compliant frameworks, explore Option Tip and SEBI Advisory.
Overall, Nuvama expects the insurer’s balanced product portfolio, sustained VNB margin, and expanding distribution base to support consistent long-term compounding. They maintain optimism on ICICI Prudential’s margin protection strategy, viewing it as a stable core insurance holding for investors seeking steady returns.
Investor Takeaway: Indian-Share-Tips.com Nifty Expert Gulshan Khera, CFP®, who is also a SEBI Regd Investment Adviser, observes that ICICI Prudential’s margin defense and balanced business mix position it well amid regulatory flux. He recommends long-term investors monitor APE growth trends and protection mix stability to identify compounding opportunities in the life insurance space.
Related Queries
Why Did Nuvama Maintain a Buy on ICICI Prudential Life Post Q2FY26?
How Is ICICI Prudential Managing Margin Stability Amid APE Decline?
What Are the Key Triggers for ICICI Prudential’s Long-Term Growth Outlook?
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment adviser before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
